Gupta, G <br/><br/>
Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosis.  [electronic resource] 

 -  Journal of the European Academy of Dermatology and Venereology : JEADV  Sep 2015 
 - 1840-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3083 
<br/><br/><label>Standard No.: </label>10.1111/jdv.12697  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Administration, Topical<br/>Aged<br/>Aminoquinolines--administration & dosage<br/>Delayed-Action Preparations<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Face<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imiquimod<br/>Keratosis, Actinic--drug therapy<br/>Male<br/>Scalp<br/>Severity of Illness Index<br/>Skin--metabolism<br/>Time Factors<br/>Treatment Outcome